This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


MTOR signaling pathway

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (10:55, 5 April 2022) (edit) (undo)
 
Line 1: Line 1:
<StructureSection load='' size='340' side='right' caption='' scene='90/908701/Rapamycin/1'>
<StructureSection load='' size='340' side='right' caption='' scene='90/908701/Rapamycin/1'>
-
'''mTOR''' (mammalian target of [[Rapamycin]]) integrates the input from insulin, growth factors and amino acids. [[Rapamycin]] inhibits mTOR by association with FKBP12<ref>PMID:22500797</ref>.
+
'''mTOR''' (mammalian target of [[Rapamycin]]) integrates the input from insulin, growth factors and amino acids. [[Rapamycin]] inhibits mTOR by association with FKBP12<ref>PMID:22500797</ref>. '''mTOR''' functions as a [[serine/threonine protein kinase]] that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, autophagy, and transcription.
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Current revision

Drag the structure with the mouse to rotate

References

  1. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012 Apr 13;149(2):274-93. doi: 10.1016/j.cell.2012.03.017. PMID:22500797 doi:http://dx.doi.org/10.1016/j.cell.2012.03.017

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky

Personal tools